Management of chronic kidney disease

Medicine

Volumn 39, Issue 7, 2011, Pages 407-413

  Tomson, Charlie ^a,b   Bailey, Pippa ^c  

^a NORTH BRISTOL NHS TRUST   (United Kingdom)

^b St Thomas' Hospital   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

antihypertensive therapy; chronic disease management; chronic kidney disease; glomerulonephritis; progression

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ACIDOSIS; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DRUG CLEARANCE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPOTENSION; HYPOVOLEMIA; KIDNEY FAILURE; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SMOKING CESSATION;

EID: 79959760490     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2011.04.006     Document Type: Review

References (42)

1. T. Bodenheimer, E.H. Wagner, and K. Grumbach Improving primary care for patients with chronic illness JAMA 288 2002 1775 1779
2. T. Bodenheimer, E.H. Wagner, and K. Grumbach Improving primary care for patients with chronic illness: the chronic care model Part 2 JAMA 288 2002 1909 1914 (Pubitemid 35168149)
3. Joint Specialty Committee for Renal Disease of the Royal College of Physicians of London and the Renal Association Chronic kidney disease in adults: UK guidelines for identification, management and referral 2006 Royal College of Physicians of London London
4. National Institute for Clinical Excellence Guideline CG73 chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care September 2008 http://guidance.nice.org.uk/CG73
5. A.S. Levey, J. Coresh, and T. Greene Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254 (Pubitemid 46768608)
6. The Royal College of Physicians of Edinburgh TSRA, and the Renal Association UK consensus statement on chronic kidney disease 2007 http://www.rcpe.ac.uk/Whats-New/consensus-statements/final-early-chronic-kidney- disease.doc
7. Scottish Intercollegiate Guidelines Network: diagnosis and management of chronic kidney disease: a national clinical guideline 2008 http://www.sign.ac. uk/guidelines/fulltext/103/index.html
8. KDOQI National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 suppl 1 February 2002 S1 S266
9. S. MacGregor Mark, and W. Taal Maarten Detection, monitoring and care of patients with chronic kidney disease August 2010 Renal Association
10. A.X. Garg, B.A. Kiberd, W.F. Clark, R.B. Haynes, and C.M. Clase Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III Kidney Int 61 2002 2165 2175 (Pubitemid 34539334)
11. S. Prakash, and A. O'Hare Interaction of aging and CKD Semin Nephrol 29 2009 September 497 503
12. R.D. Lindeman, J. Tobin, and N.W. Shock Longitudinal studies on the rate of decline in renal function with age J Am Geriatr Soc 33 1985 Apr 278 285 (Pubitemid 15087125)
13. N.T. Raymond, D. Zehnder, S.C. Smith, J.A. Stinson, H. Lehnert, and R.M. Higgins Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age Nephrol Dial Transplant 22 11 2007 Nov 3214 3220 (Pubitemid 350202561)
14. S. Klahr The modification of diet in renal disease study N Engl J Med 320 1989 Mar 30 864 866 (Pubitemid 19094709)
15. J.T. Wright Jr., G. Bakris, and T. Greene Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial JAMA 288 2002 2421 2431 (Pubitemid 35340538)
16. J.E. Heeg, P.E. de Jong, G.K. van der Hem, and D. de Zeeuw Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril Kidney Int 36 1989 272 279 (Pubitemid 19202486)
17. J.A. Arguedas, M.I. Perez, and J.M. Wright Treatment blood pressure targets for hypertension Cochrane Database Sys Rev 3 2009 Jul 8 CD004349
18. W.C. Cushman, G.W. Evans, and R.P. Byington The ACCORD Study Group Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus N Engl J Med 362 2010 1575 1585
19. A.A. Bevry, R.D. Anderson, and Y. Gong Outcomes Among Hypertensive Patients with Concomitant Peripheral and Coronary Artery Disease: findings from the International Verapamil-SR/Trandolapril Study Hypertension 55 2010 48 53
20. G.F.M. Strippoli, M.E. Craig, J.C. Craig, J. Lv, and V. Perkovic Antihypertensive agents for preventing diabetic kidney disease Cochrane Database Sys Rev 4 2005 Oct 19 CD004136
21. T.H. Jafar, P.C. Stark, and C.H. Schmid Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis Ann Intern Med 139 2003 244 252
22. National Institute for Clinical Excellence CG108 chronic heart failure management of chronic heart failure in adults in primary and secondary care August 2010
23. F.W. Asselbergs, and The Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria Circulation 110 2004 2809 2816 (Pubitemid 39473602)
24. R. Kunz, C. Friedrich, M. Wolbers, and J.F. Mann Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease Ann Intern Med 148 2008 30 48 (Pubitemid 351688350)
25. Editors of the Lancet Retraction-combination treatment of angiotensin II receptor blocker and angiotensin converting enzyme inhibitor in nondiabetic renal disease (COOPERATE): a randomized controlled trial Lancet 374 2009 1226
26. J.F. Mann, R.E. Schmieder, and M. McQueen Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial Lancet 372 2008 547 553
27. H.H. Parving, B.M. Brenner, and J.J. McMurray Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints ALTITUDE: rationale and study design Nephrol Dial Transplant 24 2009 1663 1671
28. P. Ruggenenti, A. Perna, R. Benini, and G. Remuzzi Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN) J Am Soc Nephrol 9 1998 2096 2101 (Pubitemid 28482158)
29. P. Boors, T. Ostendorf, and J. Floege Renal fibrosis: novel insights into mechanisms and therapeutic targets Nat Rev Nephrol 6 2010 643 656
30. J.E. Neter, B.E. Stam, F.J. Kok, D.E. Grobbee, and J.M. Geleijnse Influence of weight reduction on blood pressure. A meta-analysis of randomised controlled trials Hypertension 42 2003 e-publication
31. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes N Engl J Med 359 2008 1577
32. A. Patel, S. MacMahon, and J. Chalmers Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572 (Pubitemid 351831357)
33. H.C. Gerstein, M.E. Miller, and R.P. Byington Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559 (Pubitemid 351831356)
34. S. Zoungas, A. Patel, and J. Chalmers ADVANCE Collaborative Group Severe hypoglycaemia and risks of vascular events and death N Engl J Med 363 2010 Oct 7 1410 1418
35. SHARP trial www.sharpinfo.org
36. C. Wanner, V. Krane, W. März for the German Diabetes and Dialysis Study Investigators Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis N Engl J Med 353 2005 238 248 (Pubitemid 41058323)
37. B.C. Fellström, A.G. Jardine, R.E. Schmieder for The AURORA Study Group Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis N Engl J Med 360 2009 1395 1407
38. I. de Brito-Ashurst, M. Varagunam, M.J. Raftery, and M.M. Yaqoob Bicarbonate supplementation slows progression of CKD and improves nutritional status J Am Soc Nephrol 20 2009 2075 2084
39. S. Phisitkul, A. Khanna, and J. Simoni Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR Kidney Int 77 2010 617 623
40. A. Mahajan, J. Simoni, S.J. Sheather, K.R. Broglio, M.H. Rajab, and D.E. Wesson Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy Kidney Int 78 2010 303 309
41. W.M. McClellan, H. Wasse, A.C. McClellan, A. Kipp, L.A. Waller, and M.V. Rocco Treatment center and geographic variability in pre-ESRD care associate with increased mortality J Am Soc Nephrol 20 2009 1078 1085
42. T. Hasegawa, J.L. Bragg-Gresham, and S. Yamazaki Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits Clin J Am Soc Nephrol 4 2009 595 602